Expansion opportunities Recent office expansion in Pune, India signals global growth and demand for regulatory, compliance, and market access capabilities in Asia. Target partnerships or recruitment-driven offerings to support EU market and CMC module activities for local clients and multinational pharma companies expanding in Asia.

Strategic partnerships New collaborations with Helio Genomics and KAI Conversations indicate appetite for AI-powered analytics, AI-driven field insights, and advanced biopharma digital engagement. Position Syneos Health Consulting as a partner for AI-enabled clinical and commercial strategies, real-time market access intelligence, and streamlined patient engagement tools.

Digital patient engagement Award recognition for best mobile app for patient engagement and emphasis on digital innovation in patient access programs suggest opportunities to upsell or cross-sell digital health solutions, HEOR, and personalized engagement strategies to pharma clients seeking modern, tech-enabled access.

Biopharma specialization Strong focus on portfolio strategy, brand commercialization, pricing, market access and HEOR, along with R&D support, positions the firm to pursue cross-sell across existing clients and adjacent biopharma segments needing end-to-end commercialization and value-based pricing strategies.

Leadership and delivery Appointment of a Global Project Delivery head and senior leadership in project execution signals emphasis on robust delivery capabilities. Leverage leadership stability to offer enhanced program management, risk and quality assurance services, and scalable global delivery for large pharma programs.